Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Glaxo Wellcome UK Ltd., T/A GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex UB11 1BT
Betnovate Cream.
| Pharmaceutical Form |
|---|
|
Aqueous Cream. |
Betamethasone Valerate BP 0.122% W/W.
| Active Ingredient | Description | |
|---|---|---|
| Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
| List of Excipients |
|---|
|
Chlorocresol BP |
15gm, 30gm and 100gm collapsible aluminium tubes internally coated with an epoxy resin based lacquer and closed with a cap.
500mg opaque high density polythene pots with black urea formaldehyde screw caps having a steran faced wad.
Not all pack sizes may be marketed.
Glaxo Wellcome UK Ltd., T/A GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex UB11 1BT
PL10949/0014
24 October 1997
| Drug | Countries | |
|---|---|---|
| BETNOVATE | Albania, Austria, Australia, Brazil, Cyprus, Germany, Estonia, Spain, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
